MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-06-0032982
Erzek Pharmaceuticals Private Limited
Erzek Pharmaceuticals Private Limited - food and beverages in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹26.51 Lakh
▲ 9% YoY
Net loss · FY 2025
₹42,133
Net margin -1.6%
EBITDA · FY 2025
-₹35,911
EBITDA margin -1.4%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Erzek Pharmaceuticals Private Limited
Data last updated:
Erzek Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the artificial fibres segment of the food and beverages sector. It was incorporated on 15 December 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24304DL2016PTC309271. Its GSTIN is 07AAECE4688F1ZG (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Richa Madhwal and Ashish Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 21 Bf Gupta Complex Old Rohtak Road Inder Lok, New Delhi, Delhi, India – 110035.
As per the financials filed for FY 2025, the company reported a revenue of ₹26.51 Lakh, a growth of 9% compared to the previous year. For the same year it recorded a net loss of ₹42,133 (net margin -1.6%) and EBITDA of -₹35,911 (EBITDA margin -1.4%). Revenue has grown at a compounded annual rate (CAGR) of 16% over five years.
Erzek Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-06-0032982). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24304DL2016PTC309271
Registration Number 309271
Incorporation Date 15 December 2016
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-06-0032982
Key People
Richa Madhwal Director Ashish Sharma Director Recognitions & Rankings of Erzek Pharmaceuticals
Contact details
Erzek Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressB – 21 Bf Gupta Complex Old Rohtak Road Inder Lok, New Delhi, Delhi, India – 110035
- IndustryFood And Beverages, Artificial Fibres, Manufacturing
To see the full contact details of Erzek Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Erzek Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Erzek Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Erzek Pharmaceuticals Private Limited, buy the company report.
Financials of Erzek Pharmaceuticals Private Limited
FY 2025 filings availableErzek Pharmaceuticals Private Limited reported revenue of ₹26.51 Lakh (up 9% YoY) for FY 2025.
Revenue · FY 2025
₹26.51 Lakh ▲ 9%
Net loss · FY 2025
₹42,133 margin -1.6%
EBITDA · FY 2025
-₹35,911 margin -1.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 9%
5 years · compounded
▲ 16%
EBITDA CAGR growth
1 year
▲ 75%
5 years · compounded
▼ 66%
Revenue has grown at a compounded annual rate (CAGR) of 16% over five years, including 9% growth in the latest year. EBITDA rose 75% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹35,911 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹42,133 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -1.4% | ||||
| Net Profit Margin | -1.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Erzek Pharmaceuticals Private Limited, buy the company report.
Board of directors of Erzek Pharmaceuticals Private Limited
Erzek Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Richa Madhwal | Director | 26 Mar 2019 | 7 Years 7 Months | Current |
| Ashish Sharma | Director | 15 Dec 2016 | 9 Years 10 Months | Current |
Auditor
Erzek Pharmaceuticals Private Limited is audited by V P S DUDI & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V P S DUDI & CO. | FY 2017 | 028869N |
Shareholding
The shareholding of Erzek Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Erzek Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Erzek Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Erzek Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Erzek Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAECE4688F1ZG | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Erzek Pharmaceuticals Private Limited, buy the company report.
Recent activity
Erzek Pharmaceuticals Private Limited has 3 board changes on record since 2016: 2 appointments and 1 cessation. The latest: Gosangi Suresh Rao ceased to be Director on 26 Mar 2019.
AGM
Erzek Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Erzek Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Ceased
Gosangi Suresh Rao ceased to be Director.
Appointed
Richa Madhwal was appointed as Director.
Appointed
Ashish Sharma was appointed as Director.
Incorporation
15 Dec 2016
Erzek Pharmaceuticals Private Limited was registered on 15 Dec 2016 with Roc Delhi I & aged 9 years 10 months as per MCA records.
Frequently asked questions
Erzek Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in artificial fibres, within the food and beverages industry. It was incorporated on 15 December 2016 (10+ years old) and is registered under CIN U24304DL2016PTC309271.
Erzek Pharmaceuticals has 2 current directors:
- Richa Madhwal - Director
- Ashish Sharma - Director
The latest financial statements of Erzek Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Erzek Pharmaceuticals is 07AAECE4688F1ZG, registered in Delhi.
The CIN (Corporate Identification Number) of Erzek Pharmaceuticals is U24304DL2016PTC309271. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Erzek Pharmaceuticals was incorporated on 15 December 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
Gosangi Suresh Rao ceased to be Director on 26 Mar 2019. Richa Madhwal was appointed as Director on 26 Mar 2019. Ashish Sharma was appointed as Director on 15 Dec 2016.
Yes, Erzek Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-06-0032982).
The registered office of Erzek Pharmaceuticals is at B – 21 Bf Gupta Complex Old Rohtak Road Inder Lok, New Delhi, Delhi, India – 110035.
Erzek Pharmaceuticals operates in the food and beverages industry, in the artificial fibres segment.